AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving ...

British pharmaceutical giant AstraZeneca ($AZN) is one step closer to its strategic shift towards the U.S., its largest ...

AstraZeneca has seen its fair value per share revised upward from $140.96 to $144.38. This change reflects growing analyst ...

The decision by the Canadian regulator is supported by the findings from the Phase III DESTINY-Breast06 study.

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. | ...

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.

November 2025 Result of General Meeting held on 3 November 2025 AstraZeneca PLC (the 'Company') announced that at the General Meeting ('GM') of shareholders held earlier today, shareholders approved ...

WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...

The chief scientific officer of AstraZeneca says breast-cancer drugs that the company highlighted at an industry conference ...

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...

AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...

AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving ...